FIDVAXI
Genexine, Inc.
Application Filed: 2022-09-01
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79352782 |
| Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
Timeline
| 2022-09-01 | Application Filed |
| 2022-10-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-10-20 | Status: Live/Pending |
| 2022-10-21 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Genexine, Inc. |
| Address | (Magokdong, Bio Innovation Park), 172, Magokjungang-ro, Gangseo-gu Seoul KR |
| Legal Entity Type | Corporation |
| Legal Entity State | KR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Research and development of vaccines and medicines; development of cell therapy products; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; drug development; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals |
| GS0421 | Research and development of vaccines and medicines; development of new cell therapy products for others; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; Pharmaceutical drug development services; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-10-20 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-10-21 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-10-25 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-11-02 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-11-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-11-03 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-01-13 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-01-13 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-02-08 | 9 RFNT P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-06-13 | 10 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-06-13 | 11 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-06-13 | 12 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-06-13 | 13 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-06-13 | 14 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-06-13 | 15 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-07-06 | 16 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-07-06 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-07-06 | 18 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-07-28 | 19 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-08-16 | 20 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-08-16 | 21 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-08-16 | 22 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2023-09-04 | 23 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2023-09-05 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-09-05 | 25 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2023-11-21 | 26 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-11-21 | 27 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-02-21 | 28 FICR P: |
| FINAL DISPOSITION PROCESSED | 2024-02-27 | 29 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2024-02-27 | 30 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2024-03-18 | 31 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FIDVAXI 79352877 not registered Live/Pending |
Genexine, Inc. 2022-09-01 |
 FIDVAXI 79352782 not registered Live/Pending |
Genexine, Inc. 2022-09-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 